Candida infection of cerebrospinal fluid shunt devices: report of two cases and review of the literature.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10664378.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Use of CSF shunt devices is a common practice in neurosurgery, and infection of the shunt is the most frequent complication. In spite of the fact that bacteria are the most widely implicated pathogens, reports of fungal infections, especially due to Candida sp., have increased in recent years. Their reported frequency ranges between 6% and 17%. Many factors have been implicated in the pathogenesis of Candida meningitis, such as broad spectrum antibiotics used in the treatment of a bacterial meningitis, steroids and indwelling bladder and intravenous catheters. The treatment of Candida meningitis still consists of systemic antifungal agents and removal of the shunt.
Medical subject headings
- Antifungal Agents
- Candida albicans
- Meningitis, Fungal
- Ventriculoperitoneal Shunt